A recent meta-analysis of 15 case-control studies did not find any overall association [22] but this analysis was criticized by Feigelson and colleagues [23], who found a borderline significant association between the CYP17 polymorphism and advanced breast cancer. Here, CYP17A1 is linked to breast cancer.